FR2978555B1 - Utilisation du lithium et de ses derives pour le dosage des alcaloides - Google Patents

Utilisation du lithium et de ses derives pour le dosage des alcaloides

Info

Publication number
FR2978555B1
FR2978555B1 FR1157001A FR1157001A FR2978555B1 FR 2978555 B1 FR2978555 B1 FR 2978555B1 FR 1157001 A FR1157001 A FR 1157001A FR 1157001 A FR1157001 A FR 1157001A FR 2978555 B1 FR2978555 B1 FR 2978555B1
Authority
FR
France
Prior art keywords
alkaloids
assay
lithium
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1157001A
Other languages
English (en)
Other versions
FR2978555A1 (fr
Inventor
Yannick Goumon
Biehlmann Alexis Laux
Denise Stuber
Francis Schneider
Ingeborg Welters
Nadja Grafe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Strasbourg
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Strasbourg filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1157001A priority Critical patent/FR2978555B1/fr
Priority to PCT/FR2012/051788 priority patent/WO2013017788A1/fr
Publication of FR2978555A1 publication Critical patent/FR2978555A1/fr
Application granted granted Critical
Publication of FR2978555B1 publication Critical patent/FR2978555B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1157001A 2011-07-29 2011-07-29 Utilisation du lithium et de ses derives pour le dosage des alcaloides Expired - Fee Related FR2978555B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1157001A FR2978555B1 (fr) 2011-07-29 2011-07-29 Utilisation du lithium et de ses derives pour le dosage des alcaloides
PCT/FR2012/051788 WO2013017788A1 (fr) 2011-07-29 2012-07-27 Utilisation du lithium et de ses dérivés pour le dosage des alcaloïdes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1157001A FR2978555B1 (fr) 2011-07-29 2011-07-29 Utilisation du lithium et de ses derives pour le dosage des alcaloides

Publications (2)

Publication Number Publication Date
FR2978555A1 FR2978555A1 (fr) 2013-02-01
FR2978555B1 true FR2978555B1 (fr) 2013-08-23

Family

ID=46724517

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1157001A Expired - Fee Related FR2978555B1 (fr) 2011-07-29 2011-07-29 Utilisation du lithium et de ses derives pour le dosage des alcaloides

Country Status (2)

Country Link
FR (1) FR2978555B1 (fr)
WO (1) WO2013017788A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166866A (en) 1995-02-28 2000-12-26 Canon Kabushiki Kaisha Reflecting type optical system

Also Published As

Publication number Publication date
WO2013017788A1 (fr) 2013-02-07
FR2978555A1 (fr) 2013-02-01

Similar Documents

Publication Publication Date Title
FR20C1068I2 (fr) Anticorps anti-pd-l1 et leur utilisation
ZA201906378B (en) Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
HK1209373A1 (en) Anti-ly6e antibodies and immunoconjugates and methods of use ly6e
SG11201407099WA (en) Anti-pcsk9 antibodies and use thereof
EP2807479A4 (fr) Dispositifs et procédés permettant de détecter rapidement et précisément les substances à analyser
CL2015001266A1 (es) Anticuerpos de antihemaglutinina y métodos de uso.
HK1208235A1 (en) Anti-biotin antibodies and methods of use
CO7000747A2 (es) Anticuerpos anti-lrp5 y métodos de uso
MA35439B1 (fr) Inhibiteurs de l'enzyme activant nedd8
HK1191330A1 (en) Ethynyl derivatives as positive allosteric modulators of the mglur5 mglur5
HK1207659A1 (en) Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins
BR112015003032A2 (pt) anticorpos anti-jagged e métodos de utilização'.
EP2861998A4 (fr) Dispositif de dosage acellulaire et procédés d'utilisation
BR112014013746A2 (pt) aparelho de descarga e uso do aparelho de descarga
FR2975323B1 (fr) Dispositif pour l'extraction de bague
FR2975696B1 (fr) Amorces universelles et leur utilisation pour la detection et
FR2978555B1 (fr) Utilisation du lithium et de ses derives pour le dosage des alcaloides
FR2975697B1 (fr) Amorces universelles et leur utilisation pour la detection et
EP2729184A4 (fr) Nouveaux agonistes et antagonistes du système urotensinergique
FR3012750B1 (fr) Dispositif d'adsorption portatif pour le traitement du biogaz
FR2999057B3 (fr) Kit pour la preparation de gateaux
FR2988397B1 (fr) Application d'adhesifs structuraux pour le calfatage
FR2955495B1 (fr) Medicament pour la reduction de la cholesterolemie
FR3000216B1 (fr) Utilisation de proteases particulieres pour la detection de trichophytons et de pathologies associees
FR2975698B1 (fr) Amorces universelles et leur utilisation pour la detection et

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150331